Martin J. Bonick departed as Chief Executive Officer at Ardent Health, Inc..
“Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.”
Ardent Health, Inc. — fact timeline
Source-grounded facts extracted from Ardent Health, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Dave Caspers was appointed as President and Chief Executive Officer at Ardent Health, Inc..
“On June 2, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of Ardent Health, Inc. (the “Company”) appointed Dave Caspers, who previously served as the Company’s Chief Operating Officer, as the Company’s President and Chief Executive Officer and as a member of the Board.”
Ardent Health, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm at the 2026-05-20 meeting.
“The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, as follows: For Against Abstentions Broker Non-Votes 97,852,830 918,233 7,763 0”
Ardent Health, Inc. shareholders approved Advisory vote on executive compensation at the 2026-05-20 meeting.
“The stockholders approved on a non-binding advisory basis the compensation paid by the Company to its named executive officers, as disclosed in the Company’s Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 8, 2026, as follows: For Against Abstentions Broker Non-Votes 91,093,535 300,746 184,475 7,200,070”
Ardent Health, Inc. shareholders approved Election of 11 director nominees at the 2026-05-20 meeting.
“The following 11 director nominees were elected to the Company's Board of Directors, as follows: For Withhold Broker Non-Votes Mark Sotir 90,717,572 861,184 7,200,070 Martin J. Bonick 91,240,732 338,024 7,200,070 Peter Bulgarelli 91,267,887 310,869 7,200,070 Peter Bynoe 87,141,918 4,436,838 7,200,070 Suzanne Campion 91,271,694 307,062 7,200,070 Robert A. DeMichiei 91,243,922 334,834 7,200,070 William Goodyear 91,243,902 334,854 7,200,070 Ellen Havdala 86,273,698 5,305,058 7,200,070 Edmondo Robinson 91,328,193 250,563 7,200,070 Rahul Sen 79,335,440 12,243,316 7,200,070 Rob Webb 91,362,871 215,885 7,200,070”
Ardent Health, Inc. reported the first quarter ended March 31, 2026 results: revenue $1,602 million, net income $40 million, EPS $0.28 per diluted share. Guidance reaffirmed.
“period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.60 billion 7.0% growth Y/Y Net Income Attributable to Ardent Health $40 million Adjusted EBITDA (1) $124 million 26.3% growth Y/Y Adjusted EBITDAR (1) $166 million Admissions Decrease of”
Ardent Health, Inc. reported the quarter ended December 31, 2025 results: revenue $1,605 million, net income $45 million, EPS $0.32 per diluted share. Guidance initiated.
“See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue 4Q25 : $1.61 billion 2025 : $6.32 billion ; 6.0% growth Y/Y Net Income Attributable to Ardent Health 4Q25 : $45 million Adjusted EBITDA (1) 4Q25 : $134 million 2025 : $545 million ; 9.3% growth Y/Y”
Ardent Health, Inc. amended term loan with Bank of America, N.A. at Term SOFR plus 2.25% from Term SOFR plus 2.75% maturing September 18, 2032.
“extend the maturity date for the term loans from August 24, 2028 to September 18, 2032, (iii) reduce the applicable interest rate by 50 basis points from Term Secured Overnight Financing Rate (“SOFR”) plus 2.75% to Term SOFR plus 2.25%”
David Schultz departed as President, Hospital Operations at Ardent Health, Inc..
“On June 16, 2025, Ardent Health, Inc. (the “Company”) and David Schultz determined that Mr. Schultz would no longer serve as President, Hospital Operations and would depart the Company effective immediately.”
Ardent Health, Inc.: Bylaws amended and restated to reflect new company name (effective 2025-06-03).
“In conjunction with the name change, the Company's Bylaws are being amended and restated to reflect the Company's new name effective as of, and contingent upon, the effectiveness of the Amendment.”
Ardent Health, Inc.: Name change from Ardent Health Partners, Inc. to Ardent Health, Inc (effective 2025-06-03).
“On May 22, 2025, Ardent Health Partners, Inc. (the "Company") filed an amendment to its Certificate of Incorporation to change its name to Ardent Health, Inc. (the "Amendment"), effective June 3, 2025.”
Robert A. DeMichiei was appointed as director at Ardent Health, Inc..
“it has increased the size of the Company’s Board of Directors (the "Board") to 11 members and has appointed Robert A. DeMichiei to fill the newly created seat on the Board, effective April 2, 2025.”
David Caspers was appointed as Chief Operating Officer at Ardent Health, Inc..
“On March 31, 2025, Ardent Health Partners, Inc. (the “Company”) announced that David Caspers, 54, has been appointed as the Company’s Chief Operating Officer, effective March 31, 2025.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.